Chiesi Limited has issued a 'Dear Healthcare Professional' letter regarding the safe use of caffeine citrate [Peyona] 20 mg/mL ampoules

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1405, 2012-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Jones Pharma Incorporated has issued a `Dear Healthcare Professional' letter advising of changes to the US labelling of Levoxyl [levothyroxine sodium].

By  

Reactions Weekly, Vol. 1, Iss. 1023, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Cephalon has issued a "Dear Healthcare Professional" letter announcing that modafinil [Provigil] is now only indicated

By  

Reactions Weekly, Vol. 1, Iss. 1343, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Sanofi-aventis has issued a `Dear Healthcare Professional' letter outlining changes to the Ketek [telithromycin] label

By  

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Eli Lilly has issued a `Dear Healthcare Professional' letter to advise of a new warning on the US Xigris [drotrecogin alfa] label

By  

Reactions Weekly, Vol. 1, Iss. 1044-1045, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Boehringer Ingelheim Canada has issued a `Dear Health Care Professional' letter regarding intracranial haemorrhage (ICH) in patients receiving Aptivus

By  

Reactions Weekly, Vol. 1, Iss. 1110, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite